{
    "2021-09-14": [
        [
            {
                "time": "2018-01-02",
                "original_text": "AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Dips",
                        "Broader Markets"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "AbbVie Selloff Overdone, Stock Remains Undervalued: BMO",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Selloff",
                        "Undervalued",
                        "BMO"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "REGENXBIO (RGNX) Stock Up on Collaboration Deal With AbbVie",
                "features": {
                    "keywords": [
                        "REGENXBIO",
                        "Stock Up",
                        "Collaboration Deal",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "AbbVie (ABBV) to Co-Develop Regenxbio Eye Disease Gene Therapy",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Co-Develop",
                        "Regenxbio",
                        "Gene Therapy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "5 Gene Therapy Stocks Back in Focus on AbbVie/Regenxbio Deal",
                "features": {
                    "keywords": [
                        "Gene Therapy",
                        "Stocks",
                        "Focus",
                        "AbbVie/Regenxbio Deal"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "REGENXBIO (RGNX) Moves 31.2% Higher: Will This Strength Last?",
                "features": {
                    "keywords": [
                        "REGENXBIO",
                        "Moves",
                        "Higher",
                        "Strength"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}